Gregorio Martínez-Sánchez, Livan Delgado-Roche, Arquímides Díaz-Batista, Gema Pérez-Davison, Lamberto Re
Index: Eur. J. Pharmacol. 691(1-3) , 156-62, (2012)
Full Text: HTML
Coronary artery disease (CAD) is the most common cause of sudden death, and death of people over 20 years of age. Because ozone therapy can activate the antioxidant system and improve blood circulation and oxygen delivery to tissue, the aim of this study was to investigate the therapeutic efficacy of ozone in patients with CAD, treated with antithrombotic therapy, Aspirin and policosanol. A randomized controlled clinical trial was performed with 53 patients divided into two groups: one (n=27) treated with antithrombotic therapy and other (n=26) treated with antithrombotic therapy plus rectal insufflation of O(3). A parallel group (n=50) age and gender matched was used as reference for the experimental variables. The efficacy of the treatments was evaluated by comparing hemostatic indexes and biochemical markers of oxidative stress in both groups after 20 day of treatment. Ozone treatment significantly (P<0.001) improved prothrombin time when compared to the antithrombotic therapy only group, without modifying bleeding time. Combination antithrombotic therapy+O(3) improved the antioxidant status of patients reducing biomarkers of protein and lipid oxidation, enhancing total antioxidant status and modulating the level of superoxide dismutase and catalase with a 57% and 32% reduction in superoxide dismutase and catalase activities respectively, moving the redox environment to a status of low production of O(2)(•-) with an increase in H(2)O(2) detoxification. No side effects were observed. These results show that medical ozone treatment could be a complementary therapy in the treatment of CAD and its complications.Copyright © 2012 Elsevier B.V. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
1-Octacosanol
CAS:557-61-9 |
C28H58O |
In vitro and in vivo study of octacosanol metabolism.
2005-01-01 [Arch. Med. Res. 36(2) , 113-9, (2005)] |
Galactolipids from Bauhinia racemosa as a new class of antif...
2012-04-01 [Eur. J. Med. Chem. 50 , 230-5, (2012)] |
Contents and compositions of policosanols in green tea (Came...
2016-08-01 [Food Chem. 204 , 94-101, (2016)] |
Octacosanol in human health.
2003-02-01 [Nutrition 19(2) , 192-5, (2003)] |
Protective effects of octacosanol on 6-hydroxydopamine-induc...
2010-07-01 [Acta Pharmacol. Sin. 31(7) , 765-74, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved